02-Nov-2026 17:30:09

SHREE GANESH BIO Q2 : STANDALONE NET PROFIT TURNAROUND TO LOSS AT ₹8.08 L (YOY), LOSS NARROWED 85.9% (QOQ). WEAK (On 1st Look)

Revenue down 79.2% at ₹16 L (YOY), down 88.8% (QOQ). Total income down 59.0% at ₹48.28 L (YOY), down 72.4% (QOQ). PBT loss at ₹8.08 L vs profit ₹1.41 L (YOY); Q1 loss ₹57.32 L. Other income at ₹32.27 L exceeded operating revenue of ₹16 L.

Shree Ganesh Biotech (India) Ltd

← Back to feed